Amantadine hydrochloride
- Product NDC
- 69097-926
- 11-digit product format
- 690970926
- Labeler code
- 69097
- Product ID
- 69097-926_3531d73d-a0f6-48c4-9d4a-9bc630be0fe7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amantadine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA207570
- Marketing category
- ANDA
- Marketing start
- 2016-09-30
- Marketing end
- 0000-00-00
- Substance
- AMANTADINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-926-07 | 69097092607 | 100 CAPSULE in 1 BOTTLE (69097-926-07) | 100 capsule | 2016-09-30 | 0000-00-00 | No | No | Current |